Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110884734 | 11088473 | 4 | F | 2013 | 20160909 | 20150504 | 20160915 | EXP | US-PFIZER INC-2015143124 | PFIZER | 55.00 | YR | F | Y | 63.49000 | KG | 20160915 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110884734 | 11088473 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG DURING THE DAY | 21446 | 150 | MG | CAPSULE, HARD | ||||||||
110884734 | 11088473 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG AT DAY AND 150 MG BEFORE SHE WENT TO BED | 21446 | CAPSULE, HARD | BID | ||||||||
110884734 | 11088473 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 1X/DAY (ONCE A DAY Q AM) | 21446 | 75 | MG | CAPSULE, HARD | QD | ||||||
110884734 | 11088473 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 1X/DAY (ONCE A DAY Q PM) | 21446 | 150 | MG | CAPSULE, HARD | QD | ||||||
110884734 | 11088473 | 5 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
110884734 | 11088473 | 6 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
110884734 | 11088473 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
110884734 | 11088473 | 8 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | UNK, AS NEEDED | 0 | NASAL SPRAY | ||||||||||
110884734 | 11088473 | 9 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 1-2/DAY | 0 | NASAL SPRAY | ||||||||||
110884734 | 11088473 | 10 | C | ZOVIRAX | ACYCLOVIR | 1 | 400 MG, 2X/DAY | 0 | 400 | MG | BID | ||||||||
110884734 | 11088473 | 11 | C | MOBIC | MELOXICAM | 1 | 7.5 MG, 1X/DAY | 0 | 7.5 | MG | QD | ||||||||
110884734 | 11088473 | 12 | C | METOPROLOL XL | METOPROLOL SUCCINATE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | QD | ||||||||
110884734 | 11088473 | 13 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | UNK, AS NEEDED | 0 | |||||||||||
110884734 | 11088473 | 14 | C | VOLTARENE GEL | 2 | 2 G, 4X/DAY (AS NEEDED) | 0 | 2 | G | GEL | |||||||||
110884734 | 11088473 | 15 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 1-2 X/WEEK | 0 | |||||||||||
110884734 | 11088473 | 16 | C | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, 1X/DAY | 0 | 81 | MG | QD | ||||||||
110884734 | 11088473 | 17 | C | TYLENOL XL | 2 | 500 MG, AS NEEDED | 0 | 500 | MG | ||||||||||
110884734 | 11088473 | 18 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | UNK, 1X/DAY (MULTIPLE) | 0 | QD | ||||||||||
110884734 | 11088473 | 19 | C | VITAMIN C | ASCORBIC ACID | 1 | 500 MG, 1X/DAY | 0 | 500 | MG | QD | ||||||||
110884734 | 11088473 | 20 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 ?G, 1X/DAY | 0 | 1000 | UG | QD | ||||||||
110884734 | 11088473 | 21 | C | BIOTIN | BIOTIN | 1 | 5000 ?G, 1X/DAY | 0 | 5000 | UG | QD | ||||||||
110884734 | 11088473 | 22 | C | CALCIUM | CALCIUM | 1 | 600 MG, 1X/DAY | 0 | 600 | MG | QD | ||||||||
110884734 | 11088473 | 23 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 1000 IU, 1X/DAY | 0 | 1000 | IU | QD | ||||||||
110884734 | 11088473 | 24 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 400 IU, 1X/DAY | 0 | 400 | IU | QD | ||||||||
110884734 | 11088473 | 25 | C | FISH OIL | FISH OIL | 1 | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD | ||||||||
110884734 | 11088473 | 26 | C | MAGNESIUM | MAGNESIUM | 1 | 250 MG, 1X/DAY | 0 | 250 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110884734 | 11088473 | 1 | Scoliosis |
110884734 | 11088473 | 2 | Lumbar spinal stenosis |
110884734 | 11088473 | 3 | Spinal osteoarthritis |
110884734 | 11088473 | 4 | Intervertebral disc degeneration |
110884734 | 11088473 | 5 | Back disorder |
110884734 | 11088473 | 6 | Nerve injury |
110884734 | 11088473 | 7 | Sinus pain |
110884734 | 11088473 | 11 | Osteoarthritis |
110884734 | 11088473 | 12 | Cardiac disorder |
110884734 | 11088473 | 13 | Cardiac disorder |
110884734 | 11088473 | 14 | Bone pain |
110884734 | 11088473 | 15 | Vulvovaginal dryness |
110884734 | 11088473 | 16 | Cardiac disorder |
110884734 | 11088473 | 17 | Osteoarthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110884734 | 11088473 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110884734 | 11088473 | Arterial occlusive disease | |
110884734 | 11088473 | Drug intolerance | |
110884734 | 11088473 | Myocardial infarction | |
110884734 | 11088473 | Sinus congestion | |
110884734 | 11088473 | Sinusitis | |
110884734 | 11088473 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110884734 | 11088473 | 1 | 2005 | 0 |